In a significant move, hospitals across New York City have decided to sever ties with Palantir Technologies, a company that has faced scrutiny for its controversial AI practices. This decision comes as Palantir expands its operations in the United Kingdom, seeking to broaden its influence in the healthcare sector. The shift reflects growing concerns over privacy and ethical considerations surrounding the use of AI in sensitive areas such as patient data management. As Palantir moves forward in the UK, questions remain about the future of AI in healthcare and the ongoing debates about the balance between innovation and ethical responsibility.